Upcoming PFE earnings date and every past earnings report, with free AI analysis of each 10-K and 10-Q straight from SEC EDGAR filings.
November 2, 2026
Pfizer is scheduled to report earnings on this date according to earnings-calendar data from Finnhub and Financial Modeling Prep. Dates can change until the company officially confirms them.
Pfizer's Q2 FY2026 revenue grew 3% to $15.0 billion, but a $3 billion impairment and legal charge drove a net loss of $248 million, even as operating cash flow…
Pfizer reported Q1 2026 revenue of $14.45B (+5.4% YoY), but net income declined 9.4% to $2.69B as cost of revenue surged 24.7%, compressing margins despite…
Pfizer's FY2025 10-K shows a modest revenue decline of 1.6% to $62.6B alongside improved cost discipline, resulting in net income of $7.8B and solid operating…
Pfizer (PFE) is scheduled to report earnings on November 2, 2026, according to Finnhub's earnings calendar. Dates can change until the company officially confirms them.
Pfizer's most recent earnings report was its Q2 FY2026 10-Q, filed with the SEC on August 4, 2026.
EarningsLens publishes free AI analysis of every PFE 10-K and 10-Q filing. The latest covers Q2 FY2026 — open it from the report history on this page.
Like all U.S.-listed public companies, Pfizer reports four times a year: three quarterly 10-Q filings and one annual 10-K filing with the SEC.